EUVIMEDEUVIMED entdecken
Open Access

Second‐order allosteric control as a mechanism for compensatory mutations in B‐cell translocation gene 2

Nicholas J Ose, Paul Campitelli, Tushar Modi, S Banu Ozkan iD

Protein Science · 2025-09 · 34 (9)

DOI: 10.1002/pro.70270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, online erschienen am 25.08.2025. Verfasst von Nicholas J Ose und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Center for Biological Physics, Arizona State University, Tempe, Arizona, USA. Hauptthemen laut MEDLINE: Immediate-Early Proteins, Tumor Suppressor Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Gordon and Betty Moore Foundation, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanism underlying the pathogenic impact of mutations within intrinsically disordered regions of proteins remains enigmatic, and the mechanisms behind compensatory responses to these perturbations lie within an even deeper veil of obscurity. This study focuses on the compensatory mechanisms of single nucleotide variants within the disordered C‐terminal tail of the BTG2 protein, a crucial regulator in cell cycle control. Here, we develop a novel approach by combining molecular dynamics simulations with time‐dependent linear response theory to accurately compute the long‐distance coupling dynamics between the tail and the structured domain. Using this approach, we reveal how specific mutations can counteract the functional disruptions caused by a known disease‐associated mutation, V141M. Our findings demonstrate that the disordered tail regulates critical binding sites allosterically, and a weakening of this modulation may contribute to disease manifestation. However, compensatory mutations restore lost interactions between the disordered region and binding sites, exerting long‐distance dynamic control over both critical binding sites and the mutation site 141M. This secondhand allosteric control could be a general mechanism for compensatory mutations to rescue function. These insights not only illuminate the pathogenic mechanisms at play but also offer a framework for identifying potential therapeutic targets in diseases associated with disordered protein regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immediate-Early ProteinsTumor Suppressor ProteinsMolecular Dynamics SimulationAllosteric RegulationHumansMutationBinding Sites

Stichwörter der Autor:innen

allosteryintrinsically disordered regionslinear response theorymolecular dynamics simulationsprotein dynamics

Substanzen

Immediate-Early ProteinsTumor Suppressor ProteinsBTG2 protein, human

Autor:innen und Institutionen

  • Department of Physics and Center for Biological Physics, Arizona State University, Tempe, Arizona, USA.

ORCID-Profile: S Banu Ozkan

Förderung

  • NIGMS NIH HHS
  • Gordon and Betty Moore Foundation
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Ose, N. J., Campitelli, P., Modi, T., & Ozkan, S. B. (2025). Second‐order allosteric control as a mechanism for compensatory mutations in B‐cell translocation gene 2. Protein Science, 34(9). https://doi.org/10.1002/pro.70270

Vancouver

Ose NJ, Campitelli P, Modi T, Ozkan SB. Second‐order allosteric control as a mechanism for compensatory mutations in B‐cell translocation gene 2. Protein Science. 2025;34(9). doi:10.1002/pro.70270

BibTeX
@article{Ose2025,
  author = {Ose, Nicholas J and Campitelli, Paul and Modi, Tushar and Ozkan, S Banu},
  title = {Second‐order allosteric control as a mechanism for compensatory mutations in B‐cell translocation gene 2},
  journal = {Protein Science},
  year = {2025},
  volume = {34},
  number = {9},
  doi = {10.1002/pro.70270}
}
Kostenlos starten →